Literature DB >> 32212838

Circulating cell-free DNA levels are associated with adverse outcomes in heart failure: testing liquid biopsy in heart failure.

Andrea Salzano1, Muhammad Zubair Israr2, Daniel Fernandez Garcia3, Laura Middleton3, Roberta D'Assante4, Alberto M Marra4,5, Michele Arcopinto4, Yoshiyuki Yazaki2, Dennis Bernieh2, Shabana Cassambai2, Karen Page3, Giuseppe Rengo4,6, Eduardo Bossone7, Antonio Cittadini4, Jacqueline A Shaw3, Toru Suzuki2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 32212838     DOI： 10.1177/2047487320912375

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN： 2047-4873            Impact factor:   7.804


× No keyword cloud information.
  2 in total

1.  Longitudinal profiling of circulating miRNA during cardiac allograft rejection: a proof-of-concept study.

Authors:  Peter J Kennel; Alexandre Yahi; Yoshifumi Naka; Donna M Mancini; Charles C Marboe; Klaas Max; Kemal Akat; Thomas Tuschl; Elena-Rodica M Vasilescu; Emmanuel Zorn; Nicholas P Tatonetti; Paul Christian Schulze
Journal:  ESC Heart Fail       Date:  2021-03-13

Review 2.  Cell-Free DNA: Potential Application in COVID-19 Diagnostics and Management.

Authors:  Robert Stawski; Dariusz Nowak; Ewelina Perdas
Journal:  Viruses       Date:  2022-02-04       Impact factor: 5.048
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.